Pharmaceutical Lipid-Based Excipients Market Size, Share & Trends Analysis Report By Excipient Type, By Product Applications, By Disease Application, By Industry Application, By Age Group, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
  • 1.1.1 Regional Scope
  • 1.1.2 Estimates And Forecast Timeline
  • 1.1.3 Objectives
  • 1.1.4 Objective - 1
  • 1.1.5 Objective - 2
  • 1.1.6 Objective - 3
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database
  • 1.3.2 GVR's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Market Evaluation Methodology:
• 1.7 List Of Secondary Sources
• 1.8 List of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot (Regional)
• 2.2 Segment Snapshot (Excipient Type)
• 2.3 Segment Snapshot (Product Application)
• 2.4 Segment Snapshot (Disease Application)
• 2.5 Segment Snapshot (Product Industry & Age-based Product)
• 2.6 Segment Snapshot (Product Industry & Age-based Product)
• 2.7 Segment Snapshot (End-use)
• 2.8 Competitive Landscape

Chapter 3 Manufacturers Perspective: Market Variables, Trends, and Scope

• 3.1 Pharmaceutical Lipid-Based Excipients Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
    • 3.1.1.1 Excipient Market
  • 3.1.2 Ancillary Market Outlook
    • 3.1.2.1 Polymers Excipient Market
    • 3.1.2.2 Sugars Excipient Market
    • 3.1.2.3 Minerals Excipient Market
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Proliferation of Drug Candidates with Low Water Solubility and Bioavailability Challenges
    • 3.2.1.2 Growing Application of Lipid Excipients in Biologics and RNA-based Therapeutics
    • 3.2.1.3 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
  • 3.2.2 Market Opportunities Analysis
    • 3.2.2.1 Expansion of Pharmaceutical Manufacturing in Emerging Markets as a Growth Opportunity for Lipid Excipients
    • 3.2.2.2 Growth of Local Manufacturers Enhancing Competition and Innovation in the Lipid Excipients Market
  • 3.2.3 Market Restraint Analysis
    • 3.2.3.1 Price Sensitivity in Emerging Markets Restricting the Adoption of Premium Lipid Excipients
    • 3.2.3.2 Market Dominance by Key Players Restricting Entry and Innovation in Lipid Excipients Sector
  • 3.2.4 Market Challenges Analysis
    • 3.2.4.1 Substantial R&D Investment Requirements for Developing Novel Lipid Excipients and Delivery Systems
    • 3.2.4.2 Global Regulatory and Compliance Complexities Adding Operational Challenges for Lipid Excipients Manufacturers
• 3.3 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
  • 3.3.1 PORTER'S Five Forces Analysis
• 3.4 Customer Needs, Pains, and Gains Analysis

Chapter 4 Manufacturers Competitive Landscape of Lipid-based Excipients

• 4.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
• 4.2 Company Profiles for Manufacturers of Lipid Excipients
  • 4.2.1 ABITEC (ABF INGREDIENTS).
    • 4.2.1.1 Company Overview
    • 4.2.1.2 Financial Overview
    • 4.2.1.3 Product Overview
    • 4.2.1.4 Key Strategic initiatives
  • 4.2.2 BASF CORPORATION
    • 4.2.2.1 Company Overview
    • 4.2.2.2 Financial Overview
    • 4.2.2.3 Product Overview
    • 4.2.2.4 Strategic Initiatives
  • 4.2.3 GATTEFOSSE
    • 4.2.3.1 Company Overview
    • 4.2.3.2 Financial Overview
    • 4.2.3.3 Product Overview
    • 4.2.3.4 Strategic Initiatives
  • 4.2.4 CORDENPHARMA
    • 4.2.4.1 Company Overview
    • 4.2.4.2 Financial Overview
    • 4.2.4.3 Product Overview
    • 4.2.4.4 Strategic Initiatives
  • 4.2.5 LIPOID GMBH
    • 4.2.5.1 Company Overview
    • 4.2.5.2 Financial Overview
    • 4.2.5.3 product Overview
    • 4.2.5.4 Key Strategic Initiatives
  • 4.2.6 IOI OLEO GMBH
    • 4.2.6.1 Company overview
    • 4.2.6.2 Financial Overview
    • 4.2.6.3 Product Overview
    • 4.2.6.4 Strategic initiatives
  • 4.2.7 CRODA INTERNATIONAL PLC
    • 4.2.7.1 Company Overview
    • 4.2.7.2 Financial Overview
    • 4.2.7.3 Product Overview
    • 4.2.7.4 Strategic Initiatives
  • 4.2.8 EVONIK INDUSTRIES AG
    • 4.2.8.1 Company Overview
    • 4.2.8.2 Financial Overview
    • 4.2.8.3 Product Overview
    • 4.2.8.4 Strategic Initiatives
  • 4.2.9 ASHLAND
    • 4.2.9.1 Company Overview
    • 4.2.9.2 Financial Overview
    • 4.2.9.3 Product Overview
    • 4.2.9.4 Strategic Initiatives
  • 4.2.10 MERCK KGAA
    • 4.2.10.1 Company Overview
    • 4.2.10.2 Financial Overview: Thermo Fisher Scientific
    • 4.2.10.3 Product Overview
    • 4.2.10.4 Strategic Initiatives
• 4.3 Company Market Share Analysis, 2024
• 4.4 Heatmap analysis

Chapter 5 End User Perspective: Market Variables, Trends, and Scope

• 5.1 Pharmaceutical Lipid-Based Excipients Market Outlook - End User (Buyer/Consumer Companies) Perspective
  • 5.1.1 Market Driver Analysis
    • 5.1.1.1 Innovation in formulation development
    • 5.1.1.2 End user companies are formulating drugs for pediatric, geriatric, and chronic disease markets
    • 5.1.1.3 The Influence of ESG Objectives on the Adoption of Sustainable Lipid Excipients by End Users
  • 5.1.2 Market Opportunities Analysis
    • 5.1.2.1 Impact of Patent Expirations on Generic Drug Production and Lipid Excipients Demand
    • 5.1.2.2 Increasing prevalence of chronic diseases driving demand for lipid based formulations
  • 5.1.3 Market Restraint Analysis
    • 5.1.3.1 High R&D Costs, a Restraint for end use Pharmaceutical Companies Using Lipid-Based Excipients
    • 5.1.3.2 Regulatory Complexity
  • 5.1.4 Market Challenges Analysis
    • 5.1.4.1 Incompatibility with the active pharmaceutical ingredient (API)
    • 5.1.4.2 Stability and Shelf-Life Concerns
• 5.2 Pharmaceutical Lipid-Based Excipients Market Analysis Tools
  • 5.2.1 PORTER'S Five Forces Analysis

Chapter 6 End User Analysis (Buyer/Consumer Companies) Competitive Landscape

• 6.1 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
• 6.2 Buyer/Consumer Company Profiles
  • 6.2.1 TEVA PHARMACEUTICAL INDUSTRIES LTD.
    • 6.2.1.1 Company Overview
    • 6.2.1.2 Financial Overview
    • 6.2.1.3 Product Overview
    • 6.2.1.4 Key Strategic initiatives
  • 6.2.2 VIATRIS INC. (FORMERLY MYLAN)
    • 6.2.2.1 Company Overview
    • 6.2.2.2 Financial Overview
    • 6.2.2.3 PRODUCT OVERVIEW
    • 6.2.2.4 Strategic Initiatives
  • 6.2.3 SANDOZ (A DIVISION OF NOVARTIS)
    • 6.2.3.1 Company Overview
    • 6.2.3.2 Financial Overview
    • 6.2.3.3 Product Overview
  • 6.2.4 SUN PHARMACEUTICAL INDUSTRIES LTD.
    • 6.2.4.1 Company Overview
    • 6.2.4.2 Financial Overview
    • 6.2.4.3 Product Overview
  • 6.2.5 CIPLA LTD.
    • 6.2.5.1 Company Overview
    • 6.2.5.2 Financial Overview
    • 6.2.5.3 product Overview
    • 6.2.5.4 Key Strategic Initiatives
  • 6.2.6 DR. REDDY'S LABORATORIES LTD.
    • 6.2.6.1 Company overview
    • 6.2.6.2 Financial Overview
    • 6.2.6.3 Product Overview
    • 6.2.6.4 Strategic initiatives
  • 6.2.7 AUROBINDO PHARMA LTD.
    • 6.2.7.1 Company Overview
    • 6.2.7.2 Financial Overview
    • 6.2.7.3 Product Overview
    • 6.2.7.4 Strategic Initiatives
  • 6.2.8 LUPIN LTD.
    • 6.2.8.1 Company Overview
    • 6.2.8.2 Financial Overview
    • 6.2.8.3 Product Overview
  • 6.2.9 ZYDUS LIFESCIENCES LTD. (FORMERLY CADILA)
    • 6.2.9.1 Company Overview
    • 6.2.9.2 Financial Overview
    • 6.2.9.3 Product Overview
    • 6.2.9.4 Strategic Initiatives
  • 6.2.10 HIKMA PHARMACEUTICALS PLC
    • 6.2.10.1 Company Overview
    • 6.2.10.2 Financial Overview: Hikma Pharmaceuticals PLC
    • 6.2.10.3 Product Overview
• 6.3 Heatmap analysis

Chapter 7 Pharmaceutical Lipid-Based Excipients Market, By Excipient Type, 2018 - 2030 (USD Million)

• 7.1 Pharmaceutical Lipid-Based Excipients Market: Excipient Type Analysis
• 7.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Excipient Type, 2018 - 2030 (USD Million)
  • 7.2.1 Oils
    • 7.2.1.1 Sesame Oil
    • 7.2.1.2 Soybean Oil
    • 7.2.1.3 Sunflower Oil
    • 7.2.1.4 Linseed Oil /Flaxseed Oil
    • 7.2.1.5 Safflower Oil
    • 7.2.1.6 Coconut Oil
    • 7.2.1.7 Arachis Oil / Peanut Oil
    • 7.2.1.8 Corn Oil / Maize Oil
    • 7.2.1.9 Olive Oil
    • 7.2.1.10 Almond Oil
    • 7.2.1.11 Castor Oil
    • 7.2.1.12 Cotton Seed Oil
    • 7.2.1.13 Grapeseed Oil
    • 7.2.1.14 Other Oils
  • 7.2.2 Hydrogenated Vegetable Oils
  • 7.2.3 GMCC
  • 7.2.4 Hard Fats
  • 7.2.5 Medium Chain Triglycerides (MCTS)
  • 7.2.6 Lecithin And Phospholipids
  • 7.2.7 Sodium Oleate
  • 7.2.8 Capri Caprylic Mono Diglyceride
  • 7.2.9 Other Excipient Types

Chapter 8 Pharmaceutical Lipid-Based Excipients Market, By Product Applications, 2018 - 2030 (USD Million)

• 8.1 Pharmaceutical Lipid-Based Excipients Market: Product Application Analysis
• 8.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Application, 2018 - 2030 (USD Million)
  • 8.2.1 Oral Formulations
    • 8.2.1.1 Softgel Capsules
    • 8.2.1.2 Solid Dosage
    • 8.2.1.3 Liquid Oral
    • 8.2.1.4 Solid Lipid Nanoparticles (Slns)
  • 8.2.2 Parenteral
    • 8.2.2.1 Small Volume Parenteral
    • 8.2.2.2 Large Volume Parenteral
  • 8.2.3 Topical Applications
    • 8.2.3.1 Creams
    • 8.2.3.2 Ointments
    • 8.2.3.3 Other Topical Applications
  • 8.2.4 Ophthalmic Applications
    • 8.2.4.1 Eye Drops
    • 8.2.4.2 Ocular Emulsions
  • 8.2.5 Suppositories
    • 8.2.5.1 Rectal Suppositories
    • 8.2.5.2 Vaginal Suppositories
    • 8.2.5.3 Other Suppositories
  • 8.2.6 Other Product Applications

Chapter 9 Pharmaceutical Lipid-Based Excipients Market, By Disease Application, 2018 - 2030 (USD Million)

• 9.1 Pharmaceutical Lipid-Based Excipients Market: Disease Application Analysis
• 9.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Disease Application, 2018 - 2030 (USD Million)
  • 9.2.1 Cardiovascular Diseases
  • 9.2.2 Neurological Disorders
  • 9.2.3 Oncology
  • 9.2.4 Metabolic Disorders
  • 9.2.5 Hormonal Therapies
  • 9.2.6 Infectious Diseases
  • 9.2.7 Other Disease Applications

Chapter 10 Pharmaceutical Lipid-Based Excipients Market, By Product Industry, 2018 - 2030 (USD Million)

• 10.1 Pharmaceutical Lipid-Based Excipients Market: Product Industry Analysis
• 10.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Product Industry, 2018 - 2030 (USD Million)
  • 10.2.1 Pharmaceutical (OTC & RX)
  • 10.2.2 Nutraceutical (Dietary Supplements & Other)

Chapter 11 Pharmaceutical Lipid-Based Excipients Market, By Age-Based Product, 2018 - 2030 (USD Million)

• 11.1 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product Analysis
• 11.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by Age-Based Product, 2018 - 2030 (USD Million)
  • 11.2.1 Pediatric Products (0-18 Years)
  • 11.2.2 Adult Products (19-64 Years)
  • 11.2.3 Geriatric Products (65+ Years)

Chapter 12 Pharmaceutical Lipid-Based Excipients Market, By End-Use, 2018 - 2030 (USD Million)

• 12.1 Pharmaceutical Lipid-Based Excipients Market: End-Use Product Analysis
• 12.2 Pharmaceutical Lipid-Based Excipients Market, Estimates & Forecast by End-Use, 2018 - 2030 (USD Million)
  • 12.2.1 Pharmaceutical Manufacturers
  • 12.2.2 Contract Development And Manufacturing Organizations (CDMOS)
  • 12.2.3 Other

Chapter 13 Pharmaceutical Lipid-Based Excipients Market: Regional Estimates and Trend Analysis

• 13.1 Pharmaceutical Lipid-Based Excipients Market: Regional Outlook
• 13.2 North America
  • 13.2.1 North America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 13.2.2 U.S.
    • 13.2.2.1 Key Country Dynamics
    • 13.2.2.2 U.S. Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.2.2.3 Competitive/Market Scenario
    • 13.2.2.4 Regulatory Framework
  • 13.2.3 Canada
    • 13.2.3.1 Key Country Dynamics
    • 13.2.3.2 Canada Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 13.2.3.3 Competitive/Market Scenario
    • 13.2.3.4 Regulatory Framework
  • 13.2.4 Mexico
    • 13.2.4.1 Key Country Dynamics
    • 13.2.4.2 Mexico Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.2.4.3 Competitive/Market Scenario
    • 13.2.4.4 Regulatory Framework
• 13.3 Europe
  • 13.3.1 Europe Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 13.3.2 UK
    • 13.3.2.1 Key Country Dynamics
    • 13.3.2.2 UK pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 13.3.2.3 Competitive/Market Scenario
    • 13.3.2.4 Regulatory Framework
  • 13.3.3 Germany
    • 13.3.3.1 Key Country Dynamics
    • 13.3.3.2 Germany pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 13.3.3.3 Competitive/Market Scenario
    • 13.3.3.4 Regulatory Framework
  • 13.3.4 France
    • 13.3.4.1 Key Country Dynamics
    • 13.3.4.2 France pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 13.3.4.3 Competitive/Market Scenario
    • 13.3.4.4 Regulatory Framework
  • 13.3.5 Italy
    • 13.3.5.1 Key Country Dynamics
    • 13.3.5.2 Italy pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 13.3.5.3 Competitive/Market Scenario
    • 13.3.5.4 Regulatory Framework
  • 13.3.6 Spain
    • 13.3.6.1 Key Country Dynamics
    • 13.3.6.2 Spain pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 13.3.6.3 Competitive/Market Scenario
    • 13.3.6.4 Regulatory Framework
  • 13.3.7 Norway
    • 13.3.7.1 Key Country Dynamics
    • 13.3.7.2 Norway Pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 13.3.7.3 Competitive/Market Scenario
    • 13.3.7.4 Regulatory Framework
  • 13.3.8 Sweden
    • 13.3.8.1 Key Country Dynamics
    • 13.3.8.2 Sweden pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 13.3.8.3 Competitive/Market Scenario
    • 13.3.8.4 Regulatory Framework
  • 13.3.9 Denmark
    • 13.3.9.1 Key Country Dynamics
    • 13.3.9.2 Denmark Pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
    • 13.3.9.3 Competitive/Market Scenario
    • 13.3.9.4 Regulatory Framework
  • 13.3.10 Rest Of Europe Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 13.4 Asia Pacific
  • 13.4.1 Asia Pacific Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 13.4.2 China
    • 13.4.2.1 Key Country Dynamics
    • 13.4.2.2 China pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.4.2.3 Competitive/Market Scenario
    • 13.4.2.4 Regulatory Framework
  • 13.4.3 India
    • 13.4.3.1 Key Country Dynamics
    • 13.4.3.2 India pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.4.3.3 Competitive/Market Scenario
    • 13.4.3.4 Regulatory Framework
  • 13.4.4 South Korea
    • 13.4.4.1 Key Country Dynamics
    • 13.4.4.2 South Korea pharmaceutical lipid-based excipients Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 13.4.4.3 Competitive/Market Scenario
    • 13.4.4.4 Regulatory Framework
  • 13.4.5 Rest Of Asia Pacific Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 13.5 Latin America
  • 13.5.1 Latin America Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 13.5.2 Brazil
    • 13.5.2.1 Key Country Dynamics
    • 13.5.2.2 Brazil pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.5.2.3 Competitive/Market Scenario
    • 13.5.2.4 Regulatory Framework
  • 13.5.3 Argentina
    • 13.5.3.1 Key Country Dynamics
    • 13.5.3.2 Argentina pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.5.3.3 Competitive/Market Scenario
    • 13.5.3.4 Regulatory Framework
  • 13.5.4 Rest Of Latin America Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 13.6 MEA
  • 13.6.1 MEA Pharmaceutical Lipid-Based Excipients, Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 13.6.2 South Africa
    • 13.6.2.1 Key Country Dynamics
    • 13.6.2.2 South Africa Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.6.2.3 Competitive/Market Scenario
    • 13.6.2.4 Regulatory Framework
  • 13.6.3 Saudi Arabia
    • 13.6.3.1 Key Country Dynamics
    • 13.6.3.2 Saudi Arabia pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.6.3.3 Competitive/Market Scenario
    • 13.6.3.4 Regulatory Framework
  • 13.6.4 UAE
    • 13.6.4.1 Key Country Dynamics
    • 13.6.4.2 UAE pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.6.4.3 Competitive/Market Scenario
    • 13.6.4.4 Regulatory Framework
  • 13.6.5 Jordan
    • 13.6.5.1 Key Country Dynamics
    • 13.6.5.2 Jordan pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.6.5.3 Competitive/Market Scenario
    • 13.6.5.4 Regulatory Framework
  • 13.6.6 Egypt
    • 13.6.6.1 Key Country Dynamics
    • 13.6.6.2 Egypt pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.6.6.3 Competitive/Market Scenario
    • 13.6.6.4 Regulatory Framework
  • 13.6.7 Iran
    • 13.6.7.1 Key Country Dynamics
    • 13.6.7.2 Iran pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.6.7.3 Competitive/Market Scenario
    • 13.6.7.4 Regulatory Framework
  • 13.6.8 Kuwait
    • 13.6.8.1 Key Country Dynamics
    • 13.6.8.2 Kuwait pharmaceutical lipid-based excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 13.6.8.3 Competitive/Market Scenario
    • 13.6.8.4 Regulatory Framework
  • 13.6.9 Rest Of MEA Pharmaceutical Lipid-Based Excipients Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 14 Competitive Landscape

• 14.1. Market Participant Categorization
• 14.2. Company Market Position Analysis/ Heap Map Analysis
• 14.3. Strategy Mapping
  • 14.3.1. Mergers & Acquisitions
  • 14.3.2. Partnerships & Collaborations
  • 14.3.3. Others
• 14.4. Company Profiles
  • 14.4.1. ABITEC Corporation
  • 14.4.2. BASF
  • 14.4.3. Gattefosse
  • 14.4.4. CordenPharma
  • 14.4.5. Lipoid
  • 14.4.6. IOI Oleo GmbH
  • 14.4.7. Croda International
  • 14.4.8. Evonik Industries
  • 14.4.9. Ashland
  • 14.4.10. Merck KGaA

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. Company market share, 2024
• Table 4. Projected number of adults 50 years and older with chronic disease in the U.S. (in Million)
• Table 5. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by excipient type, 2018 - 2030 (USD Million)
• Table 6. Oil excipient market analysis
• Table 7. Sesame oil excipient market analysis
• Table 8. Soybean excipient market analysis
• Table 9. Sunflower excipient market analysis
• Table 10. Linseed oil /flaxseed oil excipient market analysis
• Table 11. Safflower oil excipient market analysis
• Table 12. Coconut oil excipient market analysis
• Table 13. Peanut oil excipient market analysis
• Table 14. Corn oil/ maize oil excipient market analysis
• Table 15. Olive oil excipient market analysis
• Table 16. Almond oil excipient market analysis
• Table 17. Castor oil excipient market analysis
• Table 18. Cotton seed oil excipient market analysis
• Table 19. Grape seed oil excipient market analysis
• Table 20. Cotton seed oil excipient market analysis
• Table 21. Hydrogenated vegetable oils excipient market analysis
• Table 22. GMCC excipient market analysis
• Table 23. Hard fat vegetable oils excipient market analysis
• Table 24. MCT excipient market analysis
• Table 25. Lecithin and phospholipids excipient market analysis
• Table 26. Sodium oleate excipient market analysis
• Table 27. Capri caprylic mono diglyceride excipient market analysis
• Table 28. Other types excipient market analysis
• Table 29. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product application, 2018 - 2030 (USD Million)
• Table 30. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by Disease application, 2018 - 2030 (USD Million)
• Table 31. Global heart & circulatory disease prevalence in 2021 and deaths 2021
• Table 32. Global risk factors for heart & circulatory diseases (CVD)
• Table 33. Alzheimer's disease prevalence in various countries
• Table 34. Parkinson's disease prevalence in various countries
• Table 35. New cases and deaths for 36 cancers and all cancers combined in 2022
• Table 36. Incidence and mortality rates (age-standardized rate per 100,000, cumulative risk) for 24 world areas and by sex for all cancers combined (including nonmelanoma skin cancer except basal cell carcinoma) in 2022.
• Table 37. Estimated number, percentage, and awareness of prediabetes among adults aged 18 years or older, U.S., 2017 - 2020 and 2021
• Table 38. Global diabetes data report 2000 - 2045
• Table 39. Prevalence of some of the endocrine disorders in 2022
• Table 40. Global and regional estimates of TB incidence, numbers (in thousands) and rates (per 100 000 population) in 2023
• Table 41. Global and regional estimates of TB mortality, numbers (in thousands) and rates (per 100 000 population) in 2023
• Table 42. Subgroup analysis of the prevalence of Dry Eye Disorder in Asia
• Table 43. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by product industry, 2018 - 2030 (USD Million)
• Table 44. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by age-based product, 2018 - 2030 (USD Million)
• Table 45. Pharmaceutical lipid-based excipients market, revenue estimates and forecast by end-use, 2018 - 2030 (USD Million)
• Table 46. Key lipid excipients manufacturers in the U.S.
• Table 47. Key end user of lipid excipients in the U.S.
• Table 48. Key lipid excipients manufacturers in the Canada
• Table 49. Key end user of lipid excipients in the Canada
• Table 50. Key lipid excipients manufacturers in the Mexico
• Table 51. Key end user of lipid excipients in the Mexico
• Table 52. Key lipid excipients manufacturers in the UK
• Table 53. Key end user of lipid excipients in the UK
• Table 54. Key lipid excipients manufacturers in the Germany
• Table 55. Key end user of lipid excipients in the Germany
• Table 56. Key lipid excipients manufacturers in the France
• Table 57. Key end user of lipid excipients in the France
• Table 58. Key lipid excipients manufacturers in Itay.
• Table 59. Key End users of lipid excipients in Italy
• Table 60. Key lipid excipients manufacturers in Spain.
• Table 61. Key End users of lipid excipients in Spain
• Table 62. Key lipid excipients manufacturers in the Norway.
• Table 63. Key End users of lipid excipients in the Norway
• Table 64. Key lipid excipients manufacturers in Sweden.
• Table 65. Key End users of lipid excipients in Sweden
• Table 66. Key lipid excipients manufacturers in Denmark.
• Table 67. Key End users of lipid excipients in Denmark
• Table 68. Key lipid excipients manufacturers in China.
• Table 69. Key End users of lipid excipients in China
• Table 70. Key lipid excipients manufacturers in India.
• Table 71. Key End users of lipid excipients in India
• Table 72. Key lipid excipients manufacturers in the South Korea
• Table 73. Key end user of lipid excipients in the South Korea
• Table 74. Key lipid excipients manufacturers in Brazil.
• Table 75. Key End users of lipid excipients in Brazil
• Table 76. Key lipid excipients manufacturers in Argentina.
• Table 77. Key End users of lipid excipients in Argentina
• Table 78. Key lipid excipients manufacturers in South Africa.
• Table 79. Key End users of lipid excipients in South Africa
• Table 80. Key lipid excipients manufacturers in Saudi Arabia.
• Table 81. Key End users of lipid excipients in Saudi Arabia
• Table 82. Key lipid excipients manufacturers in UAE.
• Table 83. Key End users of lipid excipients in UAE
• Table 84. Key lipid excipients manufacturers in Jordan.
• Table 85. Key End users of lipid excipients in Jordan
• Table 86. Key lipid excipients manufacturers in Egypt.
• Table 87. Key End users of lipid excipients in Egypt
• Table 88. Key lipid excipients manufacturers in Iran.
• Table 89. Key End users of lipid excipients in Iran
• Table 90. Key End users of lipid excipients in Kuwait

List of Figures

• Fig. 1 Pharmaceutical lipid-based excipients market: Market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Value chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Segment snapshot (Excipient type)
• Fig. 10 Segment snapshot (Product Application)
• Fig. 11 Segment snapshot (Disease Application)
• Fig. 12 Segment snapshot (Product industry & age-based product)
• Fig. 13 Segment snapshot (Product industry & age-based product)
• Fig. 14 Segment snapshot (End-use)
• Fig. 15 Competitive landscape
• Fig. 16 Excipients market estimates and forecast, 2018-2030, USD Million
• Fig. 17 Market dynamics
• Fig. 18 Porter's five forces analysis
• Fig. 19 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
• Fig. 20 Company market share analysis, 2024
• Fig. 21 Heatmap analysis
• Fig. 22 Porter's five forces analysis
• Fig. 23 Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
• Fig. 24 Heatmap analysis
• Fig. 25 Pharmaceutical Lipid-Based Excipients Market: Excipient Type outlook and key takeaways
• Fig. 26 Pharmaceutical Lipid-Based Excipients Market: Excipient type movement analysis
• Fig. 27 Oils market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Sesame oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Soybean oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Sunflower oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 31 Linseed oil /flaxseed oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Safflower oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Coconut oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Arachis oil / peanut oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Corn oil / maize oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 36 Olive oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 Almond oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Castor oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 39 Grapeseed oil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 40 Other oils market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Hydrogenated vegetable oils market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 GMCC market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Hard fats market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Medium Chain triglycerides (MCTs) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Lecithin and phospholipids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Sodium oleate market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Capri caprylic mono diglyceride market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Other excipient types market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 49 Pharmaceutical Lipid-Based Excipients Market: Product Application outlook and key takeaways
• Fig. 50 Pharmaceutical Lipid-Based Excipients Market: Product application movement analysis
• Fig. 51 Oral formulations market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Softgel capsules market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Solid dosage market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Liquid oral market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Parenteral market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 57 Small volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 58 Large volume parenteral market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 59 Topical applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 Creams market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 61 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Other topical applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 63 Ophthalmic applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Eye drops market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 65 Ocular emulsions market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 67 Rectal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 Vaginal suppositories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 69 Other Suppositories market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Other product applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 71 Pharmaceutical Lipid-Based Excipients Market: Disease Application outlook and key takeaways
• Fig. 72 Pharmaceutical Lipid-Based Excipients Market: Disease Application movement analysis
• Fig. 73 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Neurological disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 75 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Metabolic disorders market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 77 Hormonal therapies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 79 Other disease applications market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Pharmaceutical Lipid-Based Excipients Market Product Industry outlook and key takeaways
• Fig. 81 Pharmaceutical Lipid-Based Excipients Market: Product Industry movement analysis
• Fig. 82 Pharmaceutical (OTC & Rx) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 83 Nutraceutical (dietary supplements & other) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 Pharmaceutical Lipid-Based Excipients Market Age-Based Product outlook and key takeaways
• Fig. 85 Pharmaceutical Lipid-Based Excipients Market: Age-Based Product movement analysis
• Fig. 86 Pediatric products (0-18 years) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 87 Adult products (19-64 years) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Geriatric products (65+ years) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 89 Pharmaceutical Lipid-Based Excipients Market End-Use outlook and key takeaways
• Fig. 90 Pharmaceutical Lipid-Based Excipients Market: End-Use Product movement analysis
• Fig. 91 Pharmaceutical manufacturers market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Contract Development and Manufacturing Organizations (CDMOs) market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 93 Other market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 94 Pharmaceutical Lipid-Based Excipients Market, revenue, by region, 2024 & 2030 (USD million)
• Fig. 95 Regional marketplace: Key takeaways
• Fig. 96 Regional marketplace: Key takeaways
• Fig. 97 North America pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 98 Key country dynamics
• Fig. 99 U.S. pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD million)
• Fig. 100 Key country dynamics
• Fig. 101 Canada pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 102 Key country dynamics
• Fig. 103 Mexico pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030, USD Million
• Fig. 104 Europe pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 105 Key country dynamics
• Fig. 106 UK pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 107 Key country dynamics
• Fig. 108 Germany pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 109 Key country dynamics
• Fig. 110 France pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 111 Key country dynamics
• Fig. 112 Italy pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 113 Key country dynamics
• Fig. 114 Spain pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 115 Key country dynamics
• Fig. 116 Norway pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 117 Key country dynamics
• Fig. 118 Sweden pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 119 Key country dynamics
• Fig. 120 Denmark pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 121 Rest of Europe pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 122 Asia Pacific pharmaceutical lipid-based Excipients, market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 123 Key country dynamics
• Fig. 124 China pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 125 Key country dynamics
• Fig. 126 India pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 127 Key country dynamics
• Fig. 128 South Korea pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 129 Rest of Asia Pacific pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 130 Latin America pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 131 Key country dynamics
• Fig. 132 Brazil pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 133 Key country dynamics
• Fig. 134 Argentina pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 135 Rest of Latin America pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 136 MEA pharmaceutical lipid-based excipients, market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 137 Key country dynamics
• Fig. 138 South Africa pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 139 Key country dynamics
• Fig. 140 Saudi Arabia pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 141 Key country dynamics
• Fig. 142 UAE pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 143 Key country dynamics
• Fig. 144 Jordan pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 145 Key country dynamics
• Fig. 146 Egypt pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 147 Key country dynamics
• Fig. 148 Iran pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 149 Key country dynamics
• Fig. 150 Kuwait pharmaceutical lipid-based excipients market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 151 Rest of MEA pharmaceutical lipid-based excipients market estimates and forecasts, 2018 - 2030 (USD Million)